Plant Based Vaccines Antibodies and Biologics (PBVAB 2027)

Topics

• Plant-based protein expression systems
• Global need for vaccines and antibodies that can address large, cost-sensitive markets
• Plant viral vector expression systems
• Molecular pharming issues
• Production and scale-up
• Plant-derived antigens & adjuvants
• Purification and GHP manufacture
• Plant-derived antibodies with infectious agent targets/new targets
• Biofuels
• Regulatory control
• Delivery systems
• Containment strategies (physical/genetic)
• Preventing pathogen transmission across mucosal surfaces
• Biofortification
• Clinical trials
• Downstream processing issues
• Biosafety/regulatory/public health issues

Who should Attend

• Clinicians
• Researchers
• Regulatory/public health organizations
• Representatives from academia, industry and government
• Representatives from the veterinary, human and plant communities with an interest in immunology, vaccinology and biotechnology